User profiles for Robson J. M. Machado

Robson JM Machado

Research Associate in Statistics at University of Cambridge
Verified email at mrc-bsu.cam.ac.uk
Cited by 85

Transitions across cognitive states and death among older adults in relation to education: a multistate survival model using data from six longitudinal studies

A Robitaille, A Van Den Hout, RJM Machado… - Alzheimer's & …, 2018 - Elsevier
Introduction This study examines the role of educational attainment, an indicator of cognitive
reserve, on transitions in later life between cognitive states (normal Mini-Mental State …

Replication of overall survival, progression-free survival, and overall response in chemotherapy arms of non–small cell lung cancer trials using real-world data

…, H Trinh, S Mahrus, MT Bretscher, RJM Machado… - Clinical Cancer …, 2022 - AACR
Purpose: The utility of real-world data (RWD) for use as external controls in drug development
is informed by studies that replicate trial control arms for different endpoints. The purpose …

Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line …

C Julian, RJM Machado, S Girish, P Chanu… - Cancer …, 2022 - Wiley Online Library
Background and aim The objective of this retrospective, observational, noninterventional
cohort study was to investigate prognostic factors of overall survival (OS) in patients with …

Real-world progression-free survival as an endpoint in advanced non-small-cell lung cancer: replicating atezolizumab and docetaxel arms of the OAK Trial using data …

SK Mhatre, RJM Machado, TGN Ton, H Trinh… - medRxiv, 2022 - medrxiv.org
Background Evaluating cancer treatments in real-world data (RWD) requires informative
endpoints. Due to non-standardized data collection in RWD, it is unclear if and when common …

Flexible multistate models for interval‐censored data: Specification, estimation, and an application to ageing research

RJM Machado, A van den Hout - Statistics in medicine, 2018 - Wiley Online Library
Continuous‐time multistate survival models can be used to describe health‐related processes
over time. In the presence of interval‐censored times for transitions between the living …

Real‐World Progression‐Free Survival as an Endpoint in Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Real‐World Data

SK Mhatre, RJM Machado, TGN Ton… - Clinical …, 2023 - Wiley Online Library
Evaluating cancer treatments in real‐world data (RWD) requires informative endpoints. This
study replicated the atezolizumab and docetaxel arms of the OAK trial using RWD and …

Penalised maximum likelihood estimation in multi-state models for interval-censored data

RJM Machado, A van den Hout, G Marra - Computational statistics & data …, 2021 - Elsevier
Continuous-time multi-state Markov models can be used to describe transitions over time
across health states. Given longitudinal interval-censored data on transitions between states, …

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

…, P Sufka, PC Robinson, PM Machado… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome

S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado… - Brain, 2021 - academic.oup.com
Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus disease
2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any …

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician …

…, J Yazdany, PM Machado, PC Robinson - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood.
The aim was to examine demographic and clinical factors associated with COVID-19 …